DaVita (DVA) Stock: Charts & Financials

DaVita Inc. (DVA)DVADaVita Inc.

About DaVita Inc.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Denver, CO

78,000 employees

www.davita.com

Healthcare / Medical - Care Facilities

Sector: Healthcare
Industry: Medical - Care Facilities
CEO: Javier J. Rodriguez

View full financials

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Total Current Assets	4.06B	4.06B	4.06B	4.11B	4.09B	3.64B	3.75B	4.04B	3.47B
Cash & Cash Equivalents	726.40M	726.40M	757.75M	705.96M	708.42M	438.78M	794.93M	1.07B	416.49M
Short-Term Investments	22.30M	22.30M	24.30M	30.52M	31.01M	73.16M	51.06M	21.00M	20.69M
Cash & Short-Term Investments	748.71M	748.71M	782.05M	736.48M	739.43M	511.94M	846.00M	1.09B	437.19M
Accounts Receivable	2.98B	2.98B	2.96B	2.99B	3.00B	2.76B	2.56B	2.63B	2.73B
Inventory	141.61M	141.61M	160.63M	139.09M	146.29M	150.52M	134.56M	129.00M	126.77M
Total Assets	17.50B	17.50B	17.48B	17.74B	17.49B	17.12B	17.29B	17.50B	17.03B
Property, Plant & Equipment	5.15B	5.15B	5.21B	5.61B	5.19B	5.26B	5.33B	5.36B	5.44B
Goodwill	7.58B	7.58B	7.55B	7.54B	7.47B	7.42B	7.38B	7.23B	7.20B
Intangible Assets	229.02M	229.02M	222.13M	219.67M	211.69M	205.26M	197.43M	197.85M	191.48M
Long-Term Investments	39.47M	39.47M	198.22M	259.44M	341.86M	361.20M	370.34M	464.33M	485.49M
Total Current Liabilities	2.87B	2.87B	3.14B	3.02B	2.93B	2.91B	2.97B	2.94B	2.99B
Accounts Payable	691.26M	691.26M	696.15M	655.60M	594.40M	596.14M	547.20M	488.24M	493.53M
Short-Term Debt	112.65M	112.65M	109.20M	62.92M	182.44M	178.65M	270.87M	296.25M	537.99M
Total Liabilities	16.45B	16.45B	16.32B	16.22B	15.94B	15.46B	15.19B	15.28B	14.60B
Long-Term Debt	10.51B	10.51B	12.34B	12.28B	10.08B	9.56B	9.18B	9.26B	8.45B
Total Debt	13.22B	13.22B	15.05B	14.88B	12.82B	12.32B	12.07B	12.20B	11.68B
Net Debt (Cash)	12.49B	12.49B	14.29B	14.17B	12.11B	11.88B	11.27B	11.13B	11.26B
Total Shareholders' Equity	-755.50M	-755.50M	-651.08M	-571.87M	-369.63M	-267.10M	121.12M	386.71M	632.90M
Common Stock	69K	69K	69K	91K	91K	91K	90K	90K	90K
Retained Earnings	-179.24M	-179.24M	-328.43M	2.05B	1.90B	1.70B	1.53B	1.28B	1.06B
Current Ratio	1.42	1.42	1.29	1.36	1.39	1.25	1.26	1.37	1.16
Debt to Equity Ratio	-17.50	-17.50	-23.12	-26.02	-34.67	-46.13	99.63	31.54	18.45

Quarterly Report

TTM

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Quarter ended Jun 2024

Total Current Assets

4.06B

4.11B

4.09B

3.64B

3.75B

4.04B

3.47B

Cash & Cash Equivalents

726.40M

757.75M

705.96M

708.42M

438.78M

794.93M

1.07B

416.49M

Short-Term Investments

22.30M

24.30M

30.52M

31.01M

73.16M

51.06M

21.00M

20.69M

Cash & Short-Term Investments

748.71M

782.05M

736.48M

739.43M

511.94M

846.00M

1.09B

437.19M

Accounts Receivable

2.98B

2.96B

2.99B

3.00B

2.76B

2.56B

2.63B

2.73B

Inventory

141.61M

160.63M

139.09M

146.29M

150.52M

134.56M

129.00M

126.77M

Total Assets

17.50B

17.48B

17.74B

17.49B

17.12B

17.29B

17.50B

17.03B

Property, Plant & Equipment

5.15B

5.21B

5.61B

5.19B

5.26B

5.33B

5.36B

5.44B

Goodwill

7.58B

7.55B

7.54B

7.47B

7.42B

7.38B

7.23B

7.20B

Intangible Assets

229.02M

222.13M

219.67M

211.69M

205.26M

197.43M

197.85M

191.48M

Long-Term Investments

39.47M

198.22M

259.44M

341.86M

361.20M

370.34M

464.33M

485.49M

Total Current Liabilities

2.87B

3.14B

3.02B

2.93B

2.91B

2.97B

2.94B

2.99B

Accounts Payable

691.26M

696.15M

655.60M

594.40M

596.14M

547.20M

488.24M

493.53M

Short-Term Debt

112.65M

109.20M

62.92M

182.44M

178.65M

270.87M

296.25M

537.99M

Total Liabilities

16.45B

16.32B

16.22B

15.94B

15.46B

15.19B

15.28B

14.60B

Long-Term Debt

10.51B

12.34B

12.28B

10.08B

9.56B

9.18B

9.26B

8.45B

Total Debt

13.22B

15.05B

14.88B

12.82B

12.32B

12.07B

12.20B

11.68B

Net Debt (Cash)

12.49B

14.29B

14.17B

12.11B

11.88B

11.27B

11.13B

11.26B

Total Shareholders' Equity

-755.50M

-651.08M

-571.87M

-369.63M

-267.10M

121.12M

386.71M

632.90M

Common Stock

69K

91K

90K

Retained Earnings

-179.24M

-328.43M

2.05B

1.90B

1.70B

1.53B

1.28B

1.06B

Current Ratio

1.42

1.29

1.36

1.39

1.25

1.26

1.37

1.16

Debt to Equity Ratio

-17.50

-23.12

-26.02

-34.67

-46.13

99.63

31.54

18.45

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	4.06B	3.75B	3.14B	3.16B	3.17B	3.15B	3.69B	8.42B
Cash & Cash Equivalents	757.75M	794.93M	380.06M	244.09M	461.90M	324.96M	1.10B	323.04M
Short-Term Investments	24.30M	51.06M	11.61M	77.69M	22.31M	20.10M	11.57M	2.94M
Cash & Short-Term Investments	782.05M	846.00M	391.67M	321.78M	484.21M	345.06M	1.11B	325.97M
Accounts Receivable	2.96B	2.56B	2.42B	2.55B	2.41B	2.44B	2.31B	2.40B
Inventory	160.63M	134.56M	143.10M	109.12M	107.43M	111.63M	97.95M	107.38M
Total Assets	17.48B	17.29B	16.89B	16.93B	17.12B	16.99B	17.31B	19.11B
Property, Plant & Equipment	5.21B	5.33B	5.57B	5.92B	6.30B	6.38B	6.30B	3.39B
Goodwill	7.55B	7.38B	7.11B	7.08B	7.05B	6.92B	6.79B	6.84B
Intangible Assets	222.13M	197.43M	203.22M	182.69M	177.69M	166.59M	135.68M	118.85M
Long-Term Investments	198.22M	370.34M	593.74M	275.44M	288.39M	289.68M	278.50M	260.04M
Total Current Liabilities	3.14B	2.97B	2.64B	2.62B	2.40B	2.48B	2.37B	4.89B
Accounts Payable	696.15M	547.20M	514.53M	479.78M	402.05M	434.25M	403.84M	463.27M
Short-Term Debt	109.20M	270.87M	123.30M	231.40M	179.03M	168.54M	130.71M	1.93B
Total Liabilities	16.32B	15.19B	14.15B	14.70B	14.75B	14.09B	13.81B	14.08B
Long-Term Debt	12.34B	9.18B	8.27B	8.69B	8.73B	7.92B	7.98B	8.17B
Total Debt	15.05B	12.07B	11.12B	11.82B	11.98B	11.19B	11.18B	10.10B
Net Debt (Cash)	14.29B	11.27B	10.74B	11.58B	11.51B	10.87B	10.07B	9.78B
Total Shareholders' Equity	-651.08M	121.12M	1.06B	712.33M	755.51M	1.38B	2.13B	3.70B
Common Stock	69K	90K	89K	90K	97K	110K	126K	166K
Retained Earnings	-328.43M	1.53B	598.29M	174.49M	354.34M	852.54M	1.43B	2.74B
Current Ratio	1.29	1.26	1.19	1.20	1.32	1.27	1.56	1.72
Debt to Equity Ratio	-23.12	99.63	10.53	16.60	15.85	8.09	5.24	2.73

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

4.06B

3.75B

3.14B

3.16B

3.17B

3.15B

3.69B

8.42B

Cash & Cash Equivalents

757.75M

794.93M

380.06M

244.09M

461.90M

324.96M

1.10B

323.04M

Short-Term Investments

24.30M

51.06M

11.61M

77.69M

22.31M

20.10M

11.57M

2.94M

Cash & Short-Term Investments

782.05M

846.00M

391.67M

321.78M

484.21M

345.06M

1.11B

325.97M

Accounts Receivable

2.96B

2.56B

2.42B

2.55B

2.41B

2.44B

2.31B

2.40B

Inventory

160.63M

134.56M

143.10M

109.12M

107.43M

111.63M

97.95M

107.38M

Total Assets

17.48B

17.29B

16.89B

16.93B

17.12B

16.99B

17.31B

19.11B

Property, Plant & Equipment

5.21B

5.33B

5.57B

5.92B

6.30B

6.38B

6.30B

3.39B

Goodwill

7.55B

7.38B

7.11B

7.08B

7.05B

6.92B

6.79B

6.84B

Intangible Assets

222.13M

197.43M

203.22M

182.69M

177.69M

166.59M

135.68M

118.85M

Long-Term Investments

198.22M

370.34M

593.74M

275.44M

288.39M

289.68M

278.50M

260.04M

Total Current Liabilities

3.14B

2.97B

2.64B

2.62B

2.40B

2.48B

2.37B

4.89B

Accounts Payable

696.15M

547.20M

514.53M

479.78M

402.05M

434.25M

403.84M

463.27M

Short-Term Debt

109.20M

270.87M

123.30M

231.40M

179.03M

168.54M

130.71M

1.93B

Total Liabilities

16.32B

15.19B

14.15B

14.70B

14.75B

14.09B

13.81B

14.08B

Long-Term Debt

12.34B

9.18B

8.27B

8.69B

8.73B

7.92B

7.98B

8.17B

Total Debt

15.05B

12.07B

11.12B

11.82B

11.98B

11.19B

11.18B

10.10B

Net Debt (Cash)

14.29B

11.27B

10.74B

11.58B

11.51B

10.87B

10.07B

9.78B

Total Shareholders' Equity

-651.08M

121.12M

1.06B

712.33M

755.51M

1.38B

2.13B

3.70B

Common Stock

69K

90K

89K

90K

97K

110K

126K

166K

Retained Earnings

-328.43M

1.53B

598.29M

174.49M

354.34M

852.54M

1.43B

2.74B

Current Ratio

1.29

1.26

1.19

1.20

1.32

1.27

1.56

1.72

Debt to Equity Ratio

-23.12

99.63

10.53

16.60

15.85

8.09

5.24

2.73

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)